New highly sensitive sandwich ELISA system for soluble endoglin quantification in different biological fluids

References

• Gougos A, Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol. 1988;141:1925–1933.
   PubMed Web of Science ®Google Scholar
• Barry FP, Boynton RE, Haynesworth S, et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun. 1999;265:134–139.
   PubMed Web of Science ®Google Scholar
• St-Jacques S, Forte M, Lye SJ, et al. Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod. 1994;51:405–413.
   PubMed Web of Science ®Google Scholar
• Bellon T, Corbi A, Lastres P, et al. Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol. 1993;23:2340–2345.
   PubMed Web of Science ®Google Scholar
• Llorca O, Trujillo A, Blanco FJ, et al. Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J Mol Biol. 2007;365:694–705.
   PubMed Web of Science ®Google Scholar
• Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem. 1999;274:584–594.
   PubMed Web of Science ®Google Scholar
• Nolan-Stevaux O, Zhong W, Culp S, et al. Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies. PLoS One. 2012;7:e50920.
   PubMed Web of Science ®Google Scholar
• Nassiri F, Cusimano MD, Scheithauer BW, et al. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res. 2011;31:2283–2290.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jovanovic B, Pins M, et al. Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene. 2002;21:8272–8281.
   PubMed Web of Science ®Google Scholar
• Henry LA, Johnson DA, Sarrio D, et al. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome. Oncogene. 2011;30:1046–1058.
   PubMed Web of Science ®Google Scholar
• Hawinkels LJ, Kuiper P, Wiercinska E, et al. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res. 2010;70:4141–4150.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992–1005.
   PubMed Web of Science ®Google Scholar
• Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:1.
   Google Scholar
• Li C, Guo B, Wilson PB, et al. Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer. 2000;89:122–126.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Kawanishi-Tabata R, Haba A, et al. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin. Clin Cancer Res. 2001;7:524–532.
   PubMed Web of Science ®Google Scholar
• Fujita K, Ewing CM, Chan DY, et al. Endoglin (CD105) as a urinary and serum marker of prostate cancer. Int J Cancer. 2009;124:664–669.
   PubMed Web of Science ®Google Scholar
• Postiglione L, Di Domenico G, Caraglia M, et al. Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: implications in the modulation of cell proliferation. Int J Oncol. 2005;26:1193–1201.
   PubMed Web of Science ®Google Scholar
• Karampoor S, Zahednasab H, Ramagopalan S, et al. Angiogenic factors are associated with multiple sclerosis. J Neuroimmunol. 2016;301:88–93.
   PubMed Web of Science ®Google Scholar
• Smirnov IV, Gryazeva IV, Samoilovich MP, et al. Different pairs of monoclonal antibodies detect various amounts of soluble endoglin in human blood plasma. Immunochem Immunopathol. 2016;2.
   Google Scholar
• Smirnov IV, Griazeva IV, Samoilovich MP, et al. Production and characterization of the panel of monoclonal antibodies against human endoglin. Cell Tiss Biol. 2015;9:473–482.
   Google Scholar
• Takahashi N, Haba A, Matsuno F, et al. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Cancer Res. 2001;61:7846–7854.
   PubMed Web of Science ®Google Scholar
• Harada N, Takahashi N, Haruta Y, et al. Serum endoglin (CD105): molecular heterogeneity and marked differences among different anti-endoglin monoclonal antibodies in the detection of metastasis and tumor progression. Cancer Res. 2010;70:378.
   PubMed Web of Science ®Google Scholar
• Catty D, editor. Antibodies: a practical approach, vol.I. Oxford: IRL Press; 1988. p. 259.
   Google Scholar
• Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29:S49–S52.
   PubMedGoogle Scholar
• Wild D. The immunoassay handbook. Theory and application of ligand binding, ELISA and related techniques. 4th ed. Amsterdam: Elsevier; 2013.
   Google Scholar
• Savelieva GM, Suhih GT, Serov VN, et al., editors. Obstetrics. National guide. Moscow: GEOTAR-Media; 2015.
   Google Scholar
• Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA. 1983;80:3734–3737.
   PubMed Web of Science ®Google Scholar
• Jordan M, Schallhorn A, Wurm FM. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 1996;24:596–601.
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to Image J: 25 years of image analysis. Nat Methods. 2012;9:671–675.
   PubMed Web of Science ®Google Scholar
• Wittig I, Braun HP, Schagger H. Blue native PAGE. Nat Protoc. 2006;1:418–428.
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642–649.
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21:9–23.
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173–192.
   PubMed Web of Science ®Google Scholar
• Wang JM, Wilson PB, Kumar S, et al. Quantitation of endothelial cell specific protein E-9 employing a single monoclonal antibody in an indirect sandwich ELISA. J Immunol Methods. 1994;171:55–64.
   PubMed Web of Science ®Google Scholar
• Srinivasan B, Li Y, Jing Y, et al. A three-layer competition-based giant magnetoresistive assay for direct quantification of endoglin from human urine. Anal Chem. 2011;83:2996–3002.
   PubMed Web of Science ®Google Scholar
• Saito T, Bokhove M, Croci R, et al. Structural basis of the human endoglin-BMP9 interaction: insights into BMP signaling and HHT1. Cell Rep. 2017;19:1917–1928.
   PubMed Web of Science ®Google Scholar
• Li CG, Wilson PB, Bernabeu C, et al. Immunodetection and characterisation of soluble CD105-TGFbeta complexes. J Immunol Methods. 1998;218:85–93.
   PubMed Web of Science ®Google Scholar
• Ermini L, Ausman J, Melland-Smith M, et al. A single sphingomyelin species promotes exosomal release of endoglin into the maternal circulation in preeclampsia. Sci Rep. 2017;7:12172.
   PubMed Web of Science ®Google Scholar
• Martinez-Fierro ML, Castruita-De La Rosa C, Garza-Veloz I, et al. Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia. Hypertens Pregnancy. 2018;37:37–50.
   PubMed Web of Science ®Google Scholar